We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.
ข่าวที่เกี่ยวข้อง
- ‘Kung fu tea’: US journalist Douglas’ journey into the art of Wuyi rock tea
- Chasing the Crunch: Agoda Spotlights Under-the-Radar Asian Destinations for Autumn Foliage Season
- Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
- The Writer’s Place to Relocate Woodlands Centre to Vista Point in 2027
